Quetiapine Discontinuation Syndrome
Links shared publicly online about this topic
Efficacy and safety of quetiapine in critically il... [Crit Care Med. 2010] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 18 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on March 1, 2010 at 3:02 pm By:
William Yates, M.D. Psychiatrist, Family Medicine Doctor, Physician, and Doctor
Quetiapine (Seroquel) effective in treatment of delirium (and aids transfer to home) in ICU clinical trial. http://ow.ly/1cLun
SSRI Discontinuation or Withdrawal Syndrome | Psych Central
psychcentral.com — “After some people stop taking a type of antidepressant known as a selective serotonin reuptake inhibitor (SSRI), they experience a variety of symptoms.” View full resource at psychcentral.com
Most Recently Shared on January 3, 2011 at 8:45 pm By:
New Article: SSRI Discontinuation or Withdrawal Syndrome http://bit.ly/gc1DiP
APPRAISE-2 Study With Investigational Compound Apixaban In Acute Coronary Syndrome Discontinued
medicalnewstoday.com — “Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer (NYSE: PFE) today reported that the companies have discontinued the Phase 3 APPRAISE-2 clinical trial in patients with recent Acute Coronary Syn” View full resource at medicalnewstoday.com
Most Recently Shared on November 20, 2010 at 3:05 am By:
APPRAISE-2 Study With Investigational Compound Apixaban In Acute Coronary Syndrome Discontinued http://mnt.to/3MTp #heart #heartdisease
APPRAISE-2 Study with Investigational Compound Apixaban in Acute Coronary Syndrome Discontinued - Drugs.com MedNews
drugs.com — “Nov 18, 2010 - Bristol-Myers Squibb Company (NYSE BMY) and Pfizer (NYSE PFE) today reported that the companies have discontinued the Phase 3 APPRAISE-2 clinical” View full resource at drugs.com
Most Recently Shared on November 19, 2010 at 3:08 pm By:
Drugs and Devices OW OW Health
APPRAISE-2 Study with Investigational Compound Apixaban in Acute Coronary Syndrome Discontinued: PRINCETON... http://bit.ly/94rWRc #drug
Forum on Choosing Your Meds: Discontinuing Atripla Use
thebody.com — “Ask the experts your questions on HIV and AIDS treatment at The Body, the AIDS Authority. Got questions on starting treatment? Want to ask a question about stopping treatment? This is the place to get your questions answered!” View full resource at thebody.com
Most Recently Shared on May 10, 2010 at 6:04 pm By:
Ask the HIV/AIDS Experts: "Adverse Effects From Atripla: What's My Next Step?" http://bit.ly/ajlJuW #hiv #aids #atripla
Potential Adverse Effects of Discontinuing Psychotropic Drugs: Part 2: Antidepressant Drugs
jpnonline.com — “ABSTRACT Understanding the particular pharmacology of different antidepressant drugs can help explain their adverse effects when they are discontinued. For all antidepressant drugs, abruptly stopping” View full resource at jpnonline.com
Most Recently Shared on July 14, 2010 at 7:20 pm By:
From @JPNJournal, Potential Adverse Effects of Discontinuing Psychotropic Drugs: Part 2: Antidepressant Drugs http://ow.ly/28CZM
Dr Charles Parker on CinchCast - SSRI discontinuation syndrome is not addiction! - 154019
cinchcast.com — “Dr Charles Parker on CinchCast - SSRI discontinuation syndrome is not addiction! - 154019” View full resource at cinchcast.com
Most Recently Shared on January 11, 2011 at 5:53 pm By:
Educator, Writer, Neuroscientist, Child and Adult psychiatrist, and is certified by the Nuclear Regulatory Commission for SPECT brain imaging. He specializes in advanced diagnostic and medical services for troubled children, adolescents and adults. His broad range of clinical experience from psychoanalysis to substance abuse, to psychopharmacology and SPECT neuroimaging, – and his experience with systems/functional medicine and biomedical assessments provides a comprehensive medical foundation for treatment interventions and recommendations. If you don't look, you can't see. At CorePsych mind/brain diagnosis evolves beyond the polemics of outdated categorical thinking driven by superficial labels. Virtual assessments available anywhere globally." /> Dr Charles Parker Active Health Library, Doctor, Psychiatrist, and Physician
SSRI discontinuation syndrome is not addiction! #Cinch: http://bit.ly/eOdZmF
Discontinuation syndrome associated with paroxetin... [CNS Drugs. 2006] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on March 21, 2009 at 10:28 pm By:
Roy fromShrinkRap Doctor, Psychiatrist, and Physician
@brain_zap_queen It would be great if we had a genetic test to determine who is at higher risk of SSRI w/d http://bit.ly/unWIC
Potential Adverse Effects of Discontinuing Psychotropic Drugs -Part 3: Antipsychotic, Dopaminergic, and Mood-Stabilizing Drugs
jpnonline.com — “ABSTRACT Abrupt discontinuation of antipsychotic drugs in patients with schizophrenia is associated with earlier, and often more severe, illness episodes than are seen with gradual discontinuation. A” View full resource at jpnonline.com
Most Recently Shared on August 19, 2010 at 5:35 pm By:
From @JPNJournal, Potential Adverse Effects of Discontinuing Antipsychotic, Dopaminergic, and Mood-Stabilizing Drugs http://ow.ly/2n0ZC
Effect of early clopidogrel discontinuation on reh... [Am J Health Syst Pharm. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on May 30, 2011 at 10:46 am By:
Effect of early clopidogrel discontinuation on rehospitalization in acute coronary syndrome: Results from two di... http://bit.ly/mJS3Av
Bristol-Myers Squibb, Pfizer discontinue Phase 3 APPRAISE-2 trial in patients with ACS
news-medical.net — “Bristol-Myers Squibb Company and Pfizer today reported that the companies have discontinued the Phase 3 APPRAISE-2 clinical trial in patients with recent Acute Coronary Syndrome (ACS) treated with apixaban or placebo in addition to mono or dual antiplatelet therapy.” View full resource at news-medical.net
Most Recently Shared on November 19, 2010 at 8:26 pm By:
Stroke News: Bristol-Myers Squibb, Pfizer discontinue Phase 3 APPRAISE-2 trial in patients with ACS: Bristol-M... http://twurl.nl/hbmrnu
Withdrawal Syndromes: eMedicine Emergency Medicine
emedicine.medscape.com — “Overview: Many illicit drugs and chemicals, including medications, produce withdrawal symptoms when their use is discontinued. This article primarily focuses on withdrawal from ethanol, sedative-hypnotics, opioids, stimulants, and gamma-hydroxybutyrate (GHB).For related information, see Medscape's Addiction Resource Center. ...” View full resource at emedicine.medscape.com
Most Recently Shared on March 24, 2010 at 6:32 pm By:
Medscape Emergency Health Site
Certain risk factors associated with increased mortality in alcoholic withdrawal syndrome. See Withdrawal Syndromes http://bit.ly/dkw06I
EEG in Common Epilepsy Syndromes: eMedicine Neurology
emedicine.medscape.com — “Overview: Role of EEG in Epilepsy Syndromes EEG is an essential component in the evaluation of epilepsy. The EEG provides important information about background EEG and epileptiform discharges and is required for the diagnosis of specific electroclinical syndromes.1 ...” View full resource at emedicine.medscape.com
Most Recently Shared on June 18, 2010 at 9:49 pm By:
Medscape Neurology Neurology and Health Site
EEG in Common Epilepsy Syndromes: http://bit.ly/aiBSYF
Medical News: Trial Troubles for Novel Anti-Clotting Drug - in Cardiovascular, Acute Coronary Syndrome from MedPage Today
medpagetoday.com — “The novel antithrombotic vorapaxar got some worrying signals in two large-scale phase III trials that required changes to one trial and discontinuation of the other.” View full resource at medpagetoday.com
Most Recently Shared on January 13, 2011 at 8:37 pm By:
Trial Troubles for Novel Anti-Clotting Drug http://bit.ly/f2Keyr
Vaccine Induced Inflammation Linked To Epidemic Of Type 2 Diabetes And Metabolic Syndrome
medicalnewstoday.com — “Newly published data by Dr. J. Barthelow Classen in The Open Endocrinology Journal shows a 50% reduction of type 2 diabetes occurred in Japanese children following the discontinuation of a si” View full resource at medicalnewstoday.com
Most Recently Shared on August 9, 2011 at 4:16 pm By:
Ginger Taylor Patient Advocate
Vaccine Induced Inflammation Linked To Epidemic Of Type 2 Diabetes And Metabolic Syndrome http://t.co/M4GhQ9D via @mnt_diabetes
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
William Yates, M.D.
Clinical Neuroscientist. Research Psychiatrist, Laureate Institute of Brain Research (laureateinstitute.org) Professor of Research, University of Oklahoma.
-
Psych Central
Psychology and mental health information and support, since 1995. Pages are maintained by Brandi-Ann Uyemura, Associate Editor.
-
MNT Heart News
The latest heart and heart disease news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
